| http://www.w3.org/ns/prov#value | - We look forward to further refining ERCs to produce proteins and bioactive RNAs, both of which hold great promise to be used as therapeutics to treat conditions such as cardiovascular disease and cancer, added Samuel Broder, M.D., svp of Intrexon's health sector and former director of the NIH???s National Cancer Institute.
|
